Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1128/CMR.00005-06

http://scihub22266oqcxt.onion/10.1128/CMR.00005-06
suck pdf from google scholar
17041137!1592697!17041137
unlimited free pdf from europmc17041137    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid17041137      Clin+Microbiol+Rev 2006 ; 19 (4): 614-36
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Emerging respiratory viruses: challenges and vaccine strategies #MMPMID17041137
  • Gillim-Ross L; Subbarao K
  • Clin Microbiol Rev 2006[Oct]; 19 (4): 614-36 PMID17041137show ga
  • The current threat of avian influenza to the human population, the potential for the reemergence of severe acute respiratory syndrome (SARS)-associated coronavirus, and the identification of multiple novel respiratory viruses underline the necessity for the development of therapeutic and preventive strategies to combat viral infection. Vaccine development is a key component in the prevention of widespread viral infection and in the reduction of morbidity and mortality associated with many viral infections. In this review we describe the different approaches currently being evaluated in the development of vaccines against SARS-associated coronavirus and avian influenza viruses and also highlight the many obstacles encountered in the development of these vaccines. Lessons learned from current vaccine studies, coupled with our increasing knowledge of the host and viral factors involved in viral pathogenesis, will help to increase the speed with which efficacious vaccines targeting newly emerging viral pathogens can be developed.
  • |Animals[MESH]
  • |Humans[MESH]
  • |Influenza A virus/genetics/physiology[MESH]
  • |Influenza, Human/genetics/transmission[MESH]
  • |Metapneumovirus/isolation & purification[MESH]
  • |Paramyxoviridae Infections/epidemiology/prevention & control/virology[MESH]
  • |Respiratory Tract Infections/*epidemiology/prevention & control/virology[MESH]
  • |Severe acute respiratory syndrome-related coronavirus/isolation & purification[MESH]
  • |Viral Vaccines/*administration & dosage/immunology[MESH]
  • |Virus Diseases/*epidemiology/*prevention & control/transmission/virology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box